Pharmaceutical Technology Europe - April 2010 - (Page Cover1)

April 2010 THE PERSONALISED MEDICINE MARATHON 2 Why personalised medicine business models will require long-term strategies and great flexibility in order to be successful LATEST ISSUES, INSIGHTS AND INNOVATIONS 5 7 8 9 10 11 12 13 14 15 Science alone will not lead to better medicines The current and future market for SNPs The hype, hope and reality of pharmacogenetic tests Unravelling the human genome Progress in molecular diagnostics Personalising cancer therapy T cells for patient-specific cancer treatments Future research strategies for glucocorticoid therapy Overcoming manufacturing and financial challenges of personalised cell therapies Public-private partnerships prosper The present and the future of… Personalised medicine TOP TECHNOLOGIES 16 Eight latest technologies showcased Getty Images/Brandon Laufenberg

Table of Contents for the Digital Edition of Pharmaceutical Technology Europe - April 2010

Pharmaceutical Technology Europe - April 2010
Table of Contents
Why Personalised Medicine Business Models will Require Long-Term Strategies and Great Flexibility in Order to be Successful
Science Alone Will Not Lead to Better Medicines
The Current and Future Market for SNPs
The Hype, Hope and Reality of Pharmacogenetic Tests
Unraveling the Human Genome
Progress in Molecular Diagnostics
Personalising Cancer Therapy
T Cells for Patient-Specific Cancer Treatments
Future Research Strategies for Glucocorticoid Therapy
Overcoming Manufacturing and Financial Challenges of Personalised Cell Therapies
Public-Private Partnerships Prosper
Eight Latest Technologies Showcased

Pharmaceutical Technology Europe - April 2010